Roger Newman
Roger Newman
Send Message
Roger Newman
Stop FollowingRoger Newman
View as an RSS Feed
- MLPs And The Hidden Benefit
- AIG With A 7% Yield
- The Obama REIT: A Secure 7% Yield
- GAIN Preferred: A Monthly Pay Preferred Trading Near Call With A 7% Yield?
- Obamacare Leads To Lower Unemployment?
- Better Than A Money Market, With A Warrant To Boot
- Realty Income: A Monthly Preferred Yielding 6.5%
- The Perfect Income Security: An Update On Tortoise Energy Infrastructure Preferred CEF
- RAM Energy Partners: The Start Of Something Great Or A Terrific Short?
- Rivernorth Core Opportunity Fund: Capitalizing On CEF Pricing Inefficiencies
- A Unique Class Of Preferreds: The Perfect Income Security?
- Biotech Clinical Trials Update
- Biotech Clinical Trials Update
- Biotech Clinical Trials Update
- MAKO Surgical's Proven Model Signals Profits Ahead
- Biotech Clinical Trials Updates: Biogen, Abbott and Adolor
- Biotech Clinical Trials Update: Roche, CytRx and Actelion
- Biotech Clinical Trials Updates: Bristol Meyers, Nabi and Dynavax
- Biotech Clinical Trials Update: Sanofi, Sunshine Biopharma, Forest Labs
- Biotech Clinical Trials Update: Alkermes, Amylin and Titan
- Biotech Clinical Trials Update: Alkermes, Novartis and Pharmasset
- Biotech Clinical Trials Update: Diamyd Medical, Endo Pharmaceuticals and Medicago
- Biotech Clinical Trials Update for 3 Drug Manufacturers
- Biotech Clinical Trials Update: CRIS, ALKS, CHTP
- Transition Therapeutics: Early Stage Play for a Well Diversified Biotech Portfolio
- SodaStream: Time to Take a Sip?
- Opko Health: A Prolific Case of Insider Buying
